Frame Cancer Therapeutics Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Frame Cancer Therapeutics's estimated annual revenue is currently $4.6M per year.(i)
Frame Cancer Therapeutics's estimated revenue per employee is $201,000

Name	Title	Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Lygature	$14.7M	73	6%	N/A	N/A
#2 Lonza Netherlan...	$49.4M	246	13%	N/A	N/A
#3 ACE Pharmaceuti...	$51.3M	255	-1%	N/A	N/A
#4 Dopharma B.V.	$34.6M	172	8%	N/A	N/A
#5 Spepharm Holdin...	$251.3M	1250	6%	N/A	N/A
#6 Frame Cancer Th...	$4.6M	23	44%	N/A	N/A
#7 Norgine	$251.3M	1250	6%	N/A	N/A
#8 Sanquin Plasma	$24.3M	121	-31%	N/A	N/A
#9 Prothya Biosolu...	$90.7M	451	-8%	N/A	N/A
#10 NIA - Verenigin...	$2.4M	12	20%	N/A	N/A

keywords:N/A

N/A

Total Funding

Number of Employees

$4.6M

Revenue (est)

44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Achilles Therapeutics, Advaxis Inc, Frame Cancer Therapeutics, Genocea Biosciences Inc, Gradalis Inc, Gritstone Inc, Immunicum AB, Medigene,...

Treatment with HT-KIT prevented cancer cell growth and induced death in neoplastic mast cells over 72 hours. HT-KIT inhibits tumor growth...

Treatment with HT-KIT prevented cancer cell growth and induced death in neoplastic mast cells over 72 hours. HT-KIT inhibits tumor growth...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Mscholar	$3.3M	23	-4%	N/A
#2 Jobsrepublic	$2.3M	23	-38%	N/A
#3 Handelsverenigi...	$3.7M	23	53%	N/A
#4 Firsty.app	$5.9M	23	35%	$7M
#5 Starred	$2.3M	23	0%	N/A